Formoterol fumarate dihydrate: 6 mcg<\/li>\n<\/ul>\nTr\u00ecnh b\u00e0y<\/h3>\n
S\u0110K: 890110028723 (VN-20171-16)<\/p>\n
Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p 1 b\u00ecnh x\u1ecbt 120 li\u1ec1u<\/p>\n
Xu\u1ea5t x\u1ee9: India<\/p>\n
Combiwave FB 200 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ph\u1ed5i t\u1eafc ngh\u1ebdn m\u00e3n t\u00ednh COPD<\/figcaption><\/figure>\nT\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Combiwave FB 200<\/h2>\nC\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/h3>\n\n- Budesonide: L\u00e0 m\u1ed9t corticosteroid d\u1ea1ng h\u00edt (ICS), c\u00f3 t\u00e1c d\u1ee5ng kh\u00e1ng vi\u00eam t\u1ea1i ch\u1ed7 r\u1ea5t m\u1ea1nh. Budesonide t\u00e1c \u0111\u1ed9ng tr\u1ef1c ti\u1ebfp v\u00e0o qu\u00e1 tr\u00ecnh vi\u00eam m\u1ea1n t\u00ednh v\u1ed1n l\u00e0 g\u1ed1c r\u1ec5 c\u1ee7a b\u1ec7nh hen v\u00e0 COPD. B\u1eb1ng c\u00e1ch \u1ee9c ch\u1ebf s\u1ef1 gi\u1ea3i ph\u00f3ng c\u00e1c ch\u1ea5t trung gian g\u00e2y vi\u00eam v\u00e0 gi\u1ea3m ph\u1ea3n \u1ee9ng qu\u00e1 m\u1eabn c\u1ee7a \u0111\u01b0\u1eddng th\u1edf, Budesonide gi\u00fap gi\u1ea3m t\u1ea7n su\u1ea5t v\u00e0 m\u1ee9c \u0111\u1ed9 n\u1eb7ng c\u1ee7a c\u00e1c c\u01a1n k\u1ecbch ph\u00e1t.<\/li>\n
- Formoterol: L\u00e0 m\u1ed9t ch\u1ea5t ch\u1ee7 v\u1eadn th\u1ee5 th\u1ec3 beta-2 adrenergic t\u00e1c d\u1ee5ng k\u00e9o d\u00e0i (LABA). Khi \u0111\u01b0\u1ee3c h\u00edt v\u00e0o, Formoterol nhanh ch\u00f3ng l\u00e0m gi\u00e3n c\u01a1 tr\u01a1n ph\u1ebf qu\u1ea3n, gi\u00fap \u0111\u01b0\u1eddng th\u1edf \u0111\u01b0\u1ee3c m\u1edf r\u1ed9ng v\u00e0 th\u00f4ng tho\u00e1ng trong kho\u1ea3ng 12 gi\u1edd. T\u00e1c d\u1ee5ng n\u00e0y gi\u00fap gi\u1ea3m tri\u1ec7u ch\u1ee9ng co th\u1eaft ph\u1ebf qu\u1ea3n m\u1ed9t c\u00e1ch hi\u1ec7u qu\u1ea3.<\/li>\n<\/ul>\n
\u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/h3>\n
Khi d\u00f9ng \u1edf li\u1ec1u \u0111i\u1ec1u tr\u1ecb, c\u1ea3 Budesonide v\u00e0 Formoterol \u0111\u1ec1u c\u00f3 sinh kh\u1ea3 d\u1ee5ng to\u00e0n th\u00e2n th\u1ea5p, do ph\u1ea7n l\u1edbn thu\u1ed1c t\u00e1c \u0111\u1ed9ng t\u1ea1i ch\u1ed7 \u1edf ph\u1ed5i v\u00e0 l\u01b0\u1ee3ng thu\u1ed1c h\u1ea5p thu v\u00e0o m\u00e1u kh\u00f4ng \u0111\u00e1ng k\u1ec3. \u0110i\u1ec1u n\u00e0y gi\u00fap t\u1ed1i \u01b0u h\u00f3a hi\u1ec7u qu\u1ea3 t\u1ea1i c\u01a1 quan \u0111\u00edch v\u00e0 gi\u1ea3m thi\u1ec3u nguy c\u01a1 t\u00e1c d\u1ee5ng ph\u1ee5 to\u00e0n th\u00e2n.<\/p>\n
Thu\u1ed1c Combiwave FB 200 \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/h2>\n\n- Hen ph\u1ebf qu\u1ea3n: Combiwave FB 200<\/strong> \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong \u0111i\u1ec1u tr\u1ecb duy tr\u00ec th\u01b0\u1eddng xuy\u00ean cho b\u1ec7nh nh\u00e2n hen kh\u00f4ng \u0111\u01b0\u1ee3c ki\u1ec3m so\u00e1t t\u1ed1t b\u1eb1ng corticosteroid h\u00edt \u0111\u01a1n thu\u1ea7n v\u00e0 c\u1ea7n s\u1eed d\u1ee5ng th\u00eam thu\u1ed1c gi\u00e3n ph\u1ebf qu\u1ea3n t\u00e1c d\u1ee5ng k\u00e9o d\u00e0i.<\/li>\n
- B\u1ec7nh ph\u1ed5i t\u1eafc ngh\u1ebdn m\u1ea1n t\u00ednh (COPD): \u0110\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong \u0111i\u1ec1u tr\u1ecb tri\u1ec7u ch\u1ee9ng cho c\u00e1c b\u1ec7nh nh\u00e2n COPD n\u1eb7ng (v\u1edbi ch\u1ec9 s\u1ed1 FEV1 < 60% gi\u00e1 tr\u1ecb d\u1ef1 \u0111o\u00e1n) v\u00e0 c\u00f3 ti\u1ec1n s\u1eed c\u00e1c \u0111\u1ee3t k\u1ecbch ph\u00e1t l\u1eb7p l\u1ea1i, m\u1eb7c d\u00f9 \u0111\u00e3 \u0111i\u1ec1u tr\u1ecb th\u01b0\u1eddng xuy\u00ean b\u1eb1ng thu\u1ed1c gi\u00e3n ph\u1ebf qu\u1ea3n.<\/li>\n<\/ul>\n
Li\u1ec1u d\u00f9ng c\u1ee7a thu\u1ed1c Combiwave FB 200<\/h2>\n
Li\u1ec1u d\u00f9ng ph\u1ea3i \u0111\u01b0\u1ee3c c\u00e1 th\u1ec3 h\u00f3a v\u00e0 \u0111i\u1ec1u ch\u1ec9nh b\u1edfi b\u00e1c s\u0129. Li\u1ec1u tham kh\u1ea3o th\u00f4ng th\u01b0\u1eddng:<\/p>\n